Sudarshan Pharma’s Performance Analyzed

Sudarshan Pharma had a mixed quarter. Sales jumped significantly, increasing by 31.33% to reach Rs 168.87 crore. However, the company’s profit dropped by 28.91% to Rs 4.18 crore.

Key Points

Strong sales growth (+31.33%) observed, but profits decreased (-28.91%).

• Sales increased sharply to Rs 168.87 crore.
• Net profit fell to Rs 4.18 crore.
• Sales growth outperformed profit gains.
• Profit margin decreased considerably.
• Key financial metrics require immediate attention.
• Further investigation into cost management needed.

Detailed Breakdown

Let’s look closer at the numbers. Sales rose from Rs 128.58 crore in the previous quarter to Rs 168.87 crore. This is a positive sign showing increased demand for their products. The decrease in net profit reflects a reduction in earnings after accounting for all expenses.

The operating profit margin (OPM) also shifted, dropping from 10.15% to 5.45%. This means the company earned less profit for every rupee of sales. The profit before tax (PBT) decreased from Rs 9.00 crore to Rs 4.23 crore, and the net profit (NP) fell from Rs 5.88 crore to Rs 4.18 crore.

These changes highlight the need to understand what drove the revenue increase and why profits declined. A thorough review of the company’s costs and operations is now crucial.

Ultimately, while sales are growing, Sudarshan Pharma must improve its profitability.